MKI67 and neoplasm: All samples were stained with a sequential IHC workflow that included a panel of six antibodies for T cells subtyping (CD3, CD4, CD8 and Foxp3), proliferation (Ki67) and tumour recognition (cytokeratin) plus hematoxylin for counterstaining.